Subscribe to Newsletter

Drug Discovery

Business & Regulation Business Practice

A New Model for R&D

| 3 min read

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

Discovery & Development Drug Discovery

Can Takeda Help Treat Narcolepsy?

| 5 min read

Research and development in sleep-wake disorders has been asleep on its feet

Manufacture Bioprocessing - Upstream & Downstream

From Big Pharma to Non-Profit

| 6 min read

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

Business & Regulation Trends & Forecasts

Prioritizing Patients and Value

| 3 min read

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

Business & Regulation Trends & Forecasts

A Decade of Transformative Treatments

What trends and disruptions will shape the future of pharma? West’s Anya Harry gives her view.

Discovery & Development Drug Discovery

Addressing the Empire of Pain

| Jamie Irvine | 11 min read

How the pharma industry can help tackle the opioid crisis and advance treatments

Discovery & Development Drug Discovery

Biopharmaceuticals: Simplifying Complexity With mRNA

| Gunasekaran Kannan | 7 min read

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

Discovery & Development Drug Discovery

Cell Wars: A New Hope

| Rob Coker

Researchers use AI to reprogram glioblastoma cancer cells

Discovery & Development Clinical Trials

Inhibitors Versus Diabetes … And Dementia!

| Rob Coker

Research suggests diabetes patients using SGLT-2 and DPP-4 inhibitors have a decreased risk of developing dementia.

Discovery & Development Drug Discovery

Let’s Make a Real Difference in Cancer

| 7 min read

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register